Published in Obesity and Diabetes Week, January 17th, 2005
Final approval is expected upon the resolution of patent litigation.
Teva's Rosiglitazone Maleate Tablets are the AB-rated generic equivalent of SB Pharmaco's Avandia Tablets.
This product is indicated as an adjunct to diet and exercise in the treatment of type 2 diabetes.
The company also announced that its board of directors has increased its repurchase program to authorize the company to purchase up...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week